Levitz Michael L

EVP, CFO, TreasurerAnika Therapeutics, Inc. (ANIK) · full profile →Form 4 · filed Aug 13, 2021
Net Buying
Open-Market Buys
$146K
Open-Market Sells
$0
Net Open-Market Flow
$146K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 12, 2021Buy(P)777$40.21$31K7K
Aug 11, 2021Buy(P)3K$40.21$115K7K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001171843-21-005933) within minutes of acceptance. Every field above traces to the original document. Verify it directly: